Equus asinus breed Dezhou chromosome 27, ASM1607732v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
Donkey genomes provide new insights into domestication and selection for coat color
REFSEQ INFORMATION: The reference sequence is identical to\nCM027716.2.\nAssembly name: ASM1607732v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Dairy Cattle Research Center,\nShandong Academy of Agricultural Sciences on 2021/10/14. The\noriginal whole-genome shotgun project has the accession\nJADWZW000000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Dairy Cattle Research Center, Shandong\n Academy of Agricultural Sciences\nAssembly Method :: SOAPdenovo v. 2.04.4; DBG2OLC v. 1;\n 3D-DNA v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 211.0x\nSequencing Technology :: Illumina HiSeq; PacBio Sequel; Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Equus asinus Annotation Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
zinc finger protein 596, transcript variant X8
COORDINATES: polyA evidence [ECO:0006239]
zinc finger protein 596, transcript variant X4
zinc finger protein 596, transcript variant X9
zinc finger protein 596, transcript variant X10
zinc finger protein 596, transcript variant X5
zinc finger protein 596, transcript variant X2
zinc finger protein 596, transcript variant X3
zinc finger protein 596, transcript variant X7
zinc finger protein 596, transcript variant X1
zinc finger protein 596, transcript variant X6
zinc finger protein 596, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123281488, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123281488, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate rich 1, transcript variant X14
glutamate rich 1, transcript variant X15
glutamate rich 1, transcript variant X13
glutamate rich 1, transcript variant X12
glutamate rich 1, transcript variant X11
glutamate rich 1, transcript variant X10
glutamate rich 1, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate rich 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DLG associated protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DLG associated protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
disks large-associated protein 2 isoform X2
DLG associated protein 2, transcript variant X5
DLG associated protein 2, transcript variant X1
DLG associated protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
disks large-associated protein 2 isoform X1
disks large-associated protein 2 isoform X3
disks large-associated protein 2 isoform X4
CLN8 transmembrane ER and ERGIC protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CLN8 transmembrane ER and ERGIC protein, transcript variant X8
uncharacterized LOC123281395, transcript variant X1
uncharacterized LOC123281395, transcript variant X2
CLN8 transmembrane ER and ERGIC protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CLN8 transmembrane ER and ERGIC protein, transcript variant X5
CLN8 transmembrane ER and ERGIC protein, transcript variant X1
CLN8 transmembrane ER and ERGIC protein, transcript variant X7
CLN8 transmembrane ER and ERGIC protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CLN8 transmembrane ER and ERGIC protein, transcript variant X4
CLN8 transmembrane ER and ERGIC protein, transcript variant X9
Rho guanine nucleotide exchange factor 10, transcript variant X3
Rho guanine nucleotide exchange factor 10, transcript variant X5
Rho guanine nucleotide exchange factor 10, transcript variant X7
Rho guanine nucleotide exchange factor 10, transcript variant X8
Rho guanine nucleotide exchange factor 10, transcript variant X6
Rho guanine nucleotide exchange factor 10, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 10, transcript variant X4
Rho guanine nucleotide exchange factor 10, transcript variant X2
Rho guanine nucleotide exchange factor 10, transcript variant X1
Rho guanine nucleotide exchange factor 10, transcript variant X9
rho guanine nucleotide exchange factor 10 isoform X1
rho guanine nucleotide exchange factor 10 isoform X3
rho guanine nucleotide exchange factor 10 isoform X4
rho guanine nucleotide exchange factor 10 isoform X2
rho guanine nucleotide exchange factor 10 isoform X5
kelch repeat and BTB domain containing 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
kelch repeat and BTB domain-containing protein 11
uncharacterized LOC123281455, transcript variant X1
uncharacterized LOC123281455, transcript variant X2
uncharacterized LOC123281458, transcript variant X2
uncharacterized LOC123281458, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA
CUB and Sushi multiple domains 1, transcript variant X2
CUB and Sushi multiple domains 1, transcript variant X1
CUB and sushi domain-containing protein 1 isoform X2
CUB and sushi domain-containing protein 1 isoform X1
uncharacterized LOC123281449, transcript variant X6
uncharacterized LOC123281449, transcript variant X4
uncharacterized LOC123281449, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123281449, transcript variant X5
uncharacterized LOC123281449, transcript variant X2
uncharacterized LOC123281449, transcript variant X3
uncharacterized LOC123281482, transcript variant X1
uncharacterized LOC123281482, transcript variant X2
uncharacterized LOC123281477, transcript variant X1
uncharacterized LOC123281477, transcript variant X6
uncharacterized LOC123281477, transcript variant X4
uncharacterized LOC123281477, transcript variant X5
uncharacterized LOC123281477, transcript variant X3
uncharacterized LOC123281477, transcript variant X2
uncharacterized LOC123281470, transcript variant X2
uncharacterized LOC123281470, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1-acylglycerol-3-phosphate O-acyltransferase 5, transcript variant X1
1-acylglycerol-3-phosphate O-acyltransferase 5, transcript variant X2
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon isoform X1
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon isoform X2
uncharacterized LOC106841417, transcript variant X2
uncharacterized LOC106841417, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
defensin beta 104B, transcript variant X2
defensin beta 104B, transcript variant X3
defensin beta 104B, transcript variant X4
defensin beta 104B, transcript variant X5
defensin beta 104B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 17-like protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 596-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 705A-like, transcript variant X2
zinc finger protein 705A-like, transcript variant X3
zinc finger protein 705A-like, transcript variant X1
zinc finger protein 705A-like isoform X2
zinc finger protein 705A-like isoform X1
zinc finger protein 705A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
neuronal membrane glycoprotein M6-a isoform X2
neuronal membrane glycoprotein M6-a isoform X1
neuronal membrane glycoprotein M6-a isoform X3
WD repeat domain 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WD repeat domain 17, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat domain 17, transcript variant X1
WD repeat domain 17, transcript variant X3
WD repeat domain 17, transcript variant X5
WD repeat-containing protein 17 isoform X2
WD repeat-containing protein 17 isoform X1
WD repeat-containing protein 17 isoform X3
WD repeat domain 17, transcript variant X4
WD repeat-containing protein 17 isoform X4
WD repeat-containing protein 17 isoform X5
ankyrin repeat and SOCS box containing 5, transcript variant X3
ankyrin repeat and SOCS box containing 5, transcript variant X2
ankyrin repeat and SOCS box containing 5, transcript variant X1
ankyrin repeat and SOCS box containing 5, transcript variant X6
ankyrin repeat and SOCS box containing 5, transcript variant X4
ankyrin repeat and SOCS box containing 5, transcript variant X5
ankyrin repeat and SOCS box protein 5 isoform X1
ankyrin repeat and SOCS box protein 5 isoform X4
ankyrin repeat and SOCS box protein 5 isoform X2
ankyrin repeat and SOCS box protein 5 isoform X3
uncharacterized LOC123281446, transcript variant X7
uncharacterized LOC123281446, transcript variant X5
uncharacterized LOC123281446, transcript variant X2
uncharacterized LOC123281446, transcript variant X4
uncharacterized LOC123281446, transcript variant X1
uncharacterized LOC123281446, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123281446, transcript variant X8
uncharacterized LOC123281446, transcript variant X3
uncharacterized LOC123281444, transcript variant X2
uncharacterized LOC123281444, transcript variant X1
uncharacterized LOC123281428, transcript variant X1
uncharacterized LOC123281428, transcript variant X3
uncharacterized LOC123281428, transcript variant X2
uncharacterized LOC123281486, transcript variant X1
uncharacterized LOC123281486, transcript variant X2
nei like DNA glycosylase 3, transcript variant X1
nei like DNA glycosylase 3, transcript variant X3
nei like DNA glycosylase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 68% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123281464, transcript variant X1
uncharacterized LOC123281464, transcript variant X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
COORDINATES: nucleotide motif:Rfam:12.0:RF00099
uncharacterized LOC123281480, transcript variant X4
uncharacterized LOC123281480, transcript variant X2
uncharacterized LOC123281480, transcript variant X1
uncharacterized LOC123281480, transcript variant X3
uncharacterized LOC123281456, transcript variant X1
uncharacterized LOC123281456, transcript variant X2
teneurin transmembrane protein 3, transcript variant X2
teneurin transmembrane protein 3, transcript variant X1
teneurin transmembrane protein 3, transcript variant X3
teneurin transmembrane protein 3, transcript variant X4
teneurin transmembrane protein 3, transcript variant X5
teneurin transmembrane protein 3, transcript variant X6
teneurin transmembrane protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
WW and C2 domain containing 2, transcript variant X1
WW and C2 domain containing 2, transcript variant X2
putative claudin-24, transcript variant X3
putative claudin-24, transcript variant X2
putative claudin-24, transcript variant X1
uncharacterized LOC123281438, transcript variant X2
uncharacterized LOC123281438, transcript variant X1
uncharacterized LOC106830070, transcript variant X2
uncharacterized LOC106830070, transcript variant X1
CDKN2A interacting protein, transcript variant X2
CDKN2A interacting protein, transcript variant X1
RWD domain containing 4, transcript variant X3
RWD domain containing 4, transcript variant X2
RWD domain containing 4, transcript variant X1
RWD domain containing 4, transcript variant X4
RWD domain-containing protein 4 isoform X2
RWD domain-containing protein 4 isoform X1
RWD domain-containing protein 4 isoform X3
trafficking protein particle complex subunit 11, transcript variant X1
trafficking protein particle complex subunit 11, transcript variant X2
trafficking protein particle complex subunit 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
trafficking protein particle complex subunit 11 isoform X1
trafficking protein particle complex subunit 11 isoform X2
trafficking protein particle complex subunit 11 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ectonucleotide pyrophosphatase/phosphodiesterase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ectonucleotide pyrophosphatase/phosphodiesterase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
glycerophosphocholine cholinephosphodiesterase ENPP6 isoform X2
glycerophosphocholine cholinephosphodiesterase ENPP6 isoform X1
interferon regulatory factor 2, transcript variant X3
interferon regulatory factor 2, transcript variant X4
interferon regulatory factor 2, transcript variant X2
interferon regulatory factor 2, transcript variant X1
interferon regulatory factor 2 isoform X2
interferon regulatory factor 2 isoform X1
interferon regulatory factor 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
developmentally-regulated GTP-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
primase and DNA directed polymerase, transcript variant X7
primase and DNA directed polymerase, transcript variant X1
primase and DNA directed polymerase, transcript variant X5
primase and DNA directed polymerase, transcript variant X2
primase and DNA directed polymerase, transcript variant X3
primase and DNA directed polymerase, transcript variant X6
primase and DNA directed polymerase, transcript variant X4
DNA-directed primase/polymerase protein isoform X1
DNA-directed primase/polymerase protein isoform X2
DNA-directed primase/polymerase protein isoform X4
DNA-directed primase/polymerase protein isoform X3
primase and DNA directed polymerase, transcript variant X8
DNA-directed primase/polymerase protein isoform X5
centromere protein U, transcript variant X1
centromere protein U, transcript variant X2
acyl-CoA synthetase long chain family member 1, transcript variant X5
acyl-CoA synthetase long chain family member 1, transcript variant X4
acyl-CoA synthetase long chain family member 1, transcript variant X3
acyl-CoA synthetase long chain family member 1, transcript variant X2
acyl-CoA synthetase long chain family member 1, transcript variant X1
long-chain-fatty-acid--CoA ligase 1 isoform X3
long-chain-fatty-acid--CoA ligase 1 isoform X2
long-chain-fatty-acid--CoA ligase 1 isoform X1
long-chain-fatty-acid--CoA ligase 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
hairy and enhancer of split-related protein HELT
uncharacterized LOC106830085, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC106830085, transcript variant X1
cilia and flagella associated protein 97, transcript variant X2
cilia and flagella associated protein 97, transcript variant X3
cilia and flagella associated protein 97, transcript variant X1
cilia and flagella associated protein 97, transcript variant X4
cilia- and flagella-associated protein 97
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
LRP2 binding protein, transcript variant X1
LRP2 binding protein, transcript variant X6
LRP2 binding protein, transcript variant X5
LRP2 binding protein, transcript variant X2
LRP2 binding protein, transcript variant X4
LRP2 binding protein, transcript variant X8
LRP2 binding protein, transcript variant X3
LRP2 binding protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ankyrin repeat domain-containing protein 37
ufm1-specific protease 2, transcript variant X6
ufm1-specific protease 2, transcript variant X7
ufm1-specific protease 2, transcript variant X8
ufm1-specific protease 2, transcript variant X3
ufm1-specific protease 2, transcript variant X5
ufm1-specific protease 2, transcript variant X4
chromosome 27 C4orf47 homolog, transcript variant X1
chromosome 27 C4orf47 homolog, transcript variant X4
chromosome 27 C4orf47 homolog, transcript variant X2
chromosome 27 C4orf47 homolog, transcript variant X3
ufm1-specific protease 2, transcript variant X1
ufm1-specific protease 2, transcript variant X2
coiled-coil domain-containing protein 110 isoform X1
coiled-coil domain-containing protein 110 isoform X2
PDZ and LIM domain 3, transcript variant X2
PDZ and LIM domain 3, transcript variant X3
PDZ and LIM domain 3, transcript variant X1
sorbin and SH3 domain-containing protein 2, transcript variant X1
sorbin and SH3 domain-containing protein 2, transcript variant X2
sorbin and SH3 domain-containing protein 2, transcript variant X4
sorbin and SH3 domain-containing protein 2, transcript variant X3
sorbin and SH3 domain-containing protein 2, transcript variant X7
sorbin and SH3 domain-containing protein 2, transcript variant X6
sorbin and SH3 domain-containing protein 2, transcript variant X11
sorbin and SH3 domain-containing protein 2, transcript variant X8
sorbin and SH3 domain-containing protein 2, transcript variant X12
sorbin and SH3 domain-containing protein 2, transcript variant X9
sorbin and SH3 domain-containing protein 2, transcript variant X13
sorbin and SH3 domain-containing protein 2, transcript variant X5
sorbin and SH3 domain-containing protein 2, transcript variant X10
sorbin and SH3 domain-containing protein 2 isoform X4
sorbin and SH3 domain-containing protein 2 isoform X11
sorbin and SH3 domain-containing protein 2 isoform X13
sorbin and SH3 domain-containing protein 2 isoform X3
sorbin and SH3 domain-containing protein 2 isoform X9
sorbin and SH3 domain-containing protein 2 isoform X2
sorbin and SH3 domain-containing protein 2 isoform X12
sorbin and SH3 domain-containing protein 2 isoform X8
sorbin and SH3 domain-containing protein 2 isoform X7
sorbin and SH3 domain-containing protein 2 isoform X6
sorbin and SH3 domain-containing protein 2 isoform X1
sorbin and SH3 domain-containing protein 2 isoform X10
sorbin and SH3 domain-containing protein 2 isoform X5
toll like receptor 3, transcript variant X4
toll like receptor 3, transcript variant X3
toll like receptor 3, transcript variant X2
toll like receptor 3, transcript variant X1
family with sequence similarity 149 member A, transcript variant X1
family with sequence similarity 149 member A, transcript variant X2
family with sequence similarity 149 member A, transcript variant X3
cytochrome P450 4V2, transcript variant X2
cytochrome P450 4V2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
coagulation factor XI, transcript variant X2
coagulation factor XI, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC106840363, transcript variant X3
uncharacterized LOC106840363, transcript variant X1
uncharacterized LOC106840363, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
FAT atypical cadherin 1, transcript variant X1
FAT atypical cadherin 1, transcript variant X6
FAT atypical cadherin 1, transcript variant X5
FAT atypical cadherin 1, transcript variant X7
FAT atypical cadherin 1, transcript variant X2
FAT atypical cadherin 1, transcript variant X4
FAT atypical cadherin 1, transcript variant X3
FAT atypical cadherin 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
FAT atypical cadherin 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
FAT atypical cadherin 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
FAT atypical cadherin 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like, transcript variant X3
translation initiation factor IF-2-like, transcript variant X7
translation initiation factor IF-2-like, transcript variant X5
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like, transcript variant X6
translation initiation factor IF-2-like, transcript variant X4
translation initiation factor IF-2-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X9
translation initiation factor IF-2-like, transcript variant X11
translation initiation factor IF-2-like isoform X4
translation initiation factor IF-2-like isoform X8
translation initiation factor IF-2-like isoform X1
translation initiation factor IF-2-like isoform X2
translation initiation factor IF-2-like isoform X6
translation initiation factor IF-2-like isoform X3
translation initiation factor IF-2-like isoform X7
translation initiation factor IF-2-like, transcript variant X8
translation initiation factor IF-2-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
probable E3 ubiquitin-protein ligase TRIML2
tripartite motif family like 1, transcript variant X1
tripartite motif family like 1, transcript variant X2
probable E3 ubiquitin-protein ligase TRIML1 isoform X1
probable E3 ubiquitin-protein ligase TRIML1 isoform X2
uncharacterized LOC123281485, transcript variant X4
uncharacterized LOC123281485, transcript variant X1
uncharacterized LOC123281485, transcript variant X3
uncharacterized LOC123281485, transcript variant X2
uncharacterized LOC123281368, transcript variant X1
uncharacterized LOC123281368, transcript variant X3
uncharacterized LOC123281368, transcript variant X2
pericentriolar material 1, transcript variant X22
pericentriolar material 1, transcript variant X17
pericentriolar material 1, transcript variant X13
pericentriolar material 1, transcript variant X23
pericentriolar material 1, transcript variant X18
pericentriolar material 1, transcript variant X14
pericentriolar material 1, transcript variant X11
pericentriolar material 1, transcript variant X15
pericentriolar material 1, transcript variant X9
pericentriolar material 1, transcript variant X1
pericentriolar material 1, transcript variant X3
pericentriolar material 1, transcript variant X4
pericentriolar material 1, transcript variant X2
pericentriolar material 1, transcript variant X5
pericentriolar material 1, transcript variant X6
pericentriolar material 1, transcript variant X16
pericentriolar material 1, transcript variant X10
pericentriolar material 1, transcript variant X7
pericentriolar material 1, transcript variant X29
pericentriolar material 1, transcript variant X26
pericentriolar material 1, transcript variant X21
pericentriolar material 1, transcript variant X20
pericentriolar material 1, transcript variant X27
pericentriolar material 1, transcript variant X19
pericentriolar material 1, transcript variant X12
pericentriolar material 1, transcript variant X30
pericentriolar material 1, transcript variant X24
pericentriolar material 1, transcript variant X28
pericentriolar material 1, transcript variant X25
pericentriolar material 1 protein isoform X22
pericentriolar material 1 protein isoform X16
pericentriolar material 1 protein isoform X21
pericentriolar material 1 protein isoform X18
pericentriolar material 1 protein isoform X14
pericentriolar material 1 protein isoform X13
pericentriolar material 1 protein isoform X20
pericentriolar material 1 protein isoform X17
pericentriolar material 1 protein isoform X19
pericentriolar material 1 protein isoform X12
pericentriolar material 1 protein isoform X15
pericentriolar material 1 protein isoform X11
pericentriolar material 1 protein isoform X8
pericentriolar material 1 protein isoform X7
pericentriolar material 1 protein isoform X6
pericentriolar material 1 protein isoform X10
pericentriolar material 1 protein isoform X5
pericentriolar material 1 protein isoform X2
pericentriolar material 1 protein isoform X9
pericentriolar material 1 protein isoform X4
pericentriolar material 1 protein isoform X1
pericentriolar material 1, transcript variant X8
pericentriolar material 1 protein isoform X3
pericentriolar material 1, transcript variant X33
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
pericentriolar material 1, transcript variant X32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
pericentriolar material 1, transcript variant X31
pericentriolar material 1 protein isoform X25
pericentriolar material 1 protein isoform X24
pericentriolar material 1 protein isoform X23
fibrinogen like 1, transcript variant X1
fibrinogen like 1, transcript variant X2
uncharacterized LOC106828206, transcript variant X2
uncharacterized LOC106828206, transcript variant X1
microtubule associated scaffold protein 1, transcript variant X2
microtubule associated scaffold protein 1, transcript variant X5
microtubule associated scaffold protein 1, transcript variant X3
microtubule associated scaffold protein 1, transcript variant X9
microtubule associated scaffold protein 1, transcript variant X4
microtubule associated scaffold protein 1, transcript variant X1
microtubule associated scaffold protein 1, transcript variant X6
microtubule associated scaffold protein 1, transcript variant X7
microtubule associated scaffold protein 1, transcript variant X10
microtubule associated scaffold protein 1, transcript variant X8
microtubule-associated tumor suppressor 1 isoform X1
microtubule-associated tumor suppressor 1 isoform X2
microtubule-associated tumor suppressor 1 isoform X3
microtubule-associated tumor suppressor 1 isoform X4
microtubule associated scaffold protein 1, transcript variant X12
microtubule associated scaffold protein 1, transcript variant X11
microtubule-associated tumor suppressor 1 isoform X5
microtubule-associated tumor suppressor 1 isoform X6
microtubule associated scaffold protein 1, transcript variant X15
microtubule-associated tumor suppressor 1 isoform X9
microtubule associated scaffold protein 1, transcript variant X16
microtubule associated scaffold protein 1, transcript variant X13
microtubule-associated tumor suppressor 1 isoform X7
microtubule-associated tumor suppressor 1 isoform X10
microtubule associated scaffold protein 1, transcript variant X14
microtubule-associated tumor suppressor 1 isoform X8
platelet derived growth factor receptor like
platelet-derived growth factor receptor-like protein
solute carrier family 7 member 2, transcript variant X6
solute carrier family 7 member 2, transcript variant X5
solute carrier family 7 member 2, transcript variant X2
solute carrier family 7 member 2, transcript variant X1
solute carrier family 7 member 2, transcript variant X4
solute carrier family 7 member 2, transcript variant X3
cationic amino acid transporter 2 isoform X2
cationic amino acid transporter 2 isoform X1
cationic amino acid transporter 2 isoform X4
cationic amino acid transporter 2 isoform X3
cationic amino acid transporter 2 isoform X5
LOW QUALITY PROTEIN: myotubularin-related protein 7
VPS37A subunit of ESCRT-I, transcript variant X2
VPS37A subunit of ESCRT-I, transcript variant X1
vacuolar protein sorting-associated protein 37A isoform X1
vacuolar protein sorting-associated protein 37A isoform X2
CCR4-NOT transcription complex subunit 7, transcript variant X1
CCR4-NOT transcription complex subunit 7, transcript variant X2
CCR4-NOT transcription complex subunit 7
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X5
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X3
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X4
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X2
mitochondrial calcium uptake family member 3, transcript variant X4
mitochondrial calcium uptake family member 3, transcript variant X2
mitochondrial calcium uptake family member 3, transcript variant X3
mitochondrial calcium uptake family member 3, transcript variant X1
calcium uptake protein 3, mitochondrial isoform X4
calcium uptake protein 3, mitochondrial isoform X2
calcium uptake protein 3, mitochondrial isoform X3
calcium uptake protein 3, mitochondrial isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
macrophage scavenger receptor types I and II
tumor suppressor candidate 3, transcript variant X2
tumor suppressor candidate 3, transcript variant X1
tumor suppressor candidate 3, transcript variant X4
tumor suppressor candidate 3, transcript variant X5
tumor suppressor candidate 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 7, transcript variant X1
rho GTPase-activating protein 7 isoform X1
rho GTPase-activating protein 7, transcript variant X2
rho GTPase-activating protein 7 isoform X2
rho GTPase-activating protein 7, transcript variant X3
rho GTPase-activating protein 7 isoform X3
tRNA methyltransferase 9B (putative), transcript variant X2
tRNA methyltransferase 9B (putative), transcript variant X1
tRNA methyltransferase 9B (putative), transcript variant X3
probable tRNA methyltransferase 9B isoform X1
probable tRNA methyltransferase 9B isoform X2
probable tRNA methyltransferase 9B isoform X3
LON peptidase N-terminal domain and ring finger 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
LON peptidase N-terminal domain and ring finger 1, transcript variant X6
LON peptidase N-terminal domain and ring finger 1, transcript variant X5
LON peptidase N-terminal domain and ring finger 1, transcript variant X8
LON peptidase N-terminal domain and ring finger 1, transcript variant X4
LON peptidase N-terminal domain and ring finger 1, transcript variant X7
LON peptidase N-terminal domain and ring finger 1, transcript variant X1
LON peptidase N-terminal domain and ring finger 1, transcript variant X2
LON peptidase N-terminal domain and RING finger protein 1 isoform X5
LON peptidase N-terminal domain and RING finger protein 1 isoform X4
LON peptidase N-terminal domain and RING finger protein 1 isoform X1
LON peptidase N-terminal domain and RING finger protein 1 isoform X2
LON peptidase N-terminal domain and RING finger protein 1 isoform X3
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X2
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X1
uncharacterized LOC123281414, transcript variant X2
uncharacterized LOC123281414, transcript variant X1
low-density lipoprotein receptor-related protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 2-like, transcript variant X1
low-density lipoprotein receptor-related protein 2-like isoform X2
low-density lipoprotein receptor-related protein 2-like isoform X1
multifunctional ROCO family signaling regulator 1, transcript variant X2
multifunctional ROCO family signaling regulator 1, transcript variant X1
malignant fibrous histiocytoma-amplified sequence 1
exoribonuclease 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
exoribonuclease 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
exoribonuclease 1, transcript variant X1
exoribonuclease 1, transcript variant X7
exoribonuclease 1, transcript variant X5
exoribonuclease 1, transcript variant X2
exoribonuclease 1, transcript variant X6
exoribonuclease 1, transcript variant X8
protein phosphatase 1 regulatory subunit 3B, transcript variant X1
protein phosphatase 1 regulatory subunit 3B, transcript variant X2
protein phosphatase 1 regulatory subunit 3B isoform X1
protein phosphatase 1 regulatory subunit 3B isoform X2
uncharacterized LOC123281474, transcript variant X2
uncharacterized LOC123281474, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 3% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
poly [ADP-ribose] polymerase tankyrase-1 isoform X1
poly [ADP-ribose] polymerase tankyrase-1 isoform X2
uncharacterized LOC123281391, transcript variant X1
uncharacterized LOC123281391, transcript variant X2
store-operated calcium entry associated regulatory factor, transcript variant X2
store-operated calcium entry associated regulatory factor, transcript variant X1
store-operated calcium entry-associated regulatory factor isoform X2
store-operated calcium entry-associated regulatory factor isoform X1
leptin receptor overlapping transcript like 1
leptin receptor overlapping transcript-like 1
membrane bound O-acyltransferase domain containing 4, transcript variant X2
membrane bound O-acyltransferase domain containing 4, transcript variant X3
membrane bound O-acyltransferase domain containing 4, transcript variant X1
membrane bound O-acyltransferase domain containing 4, transcript variant X4
dynactin subunit 6, transcript variant X1
dynactin subunit 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RNA binding protein, mRNA processing factor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
RNA binding protein, mRNA processing factor, transcript variant X4
RNA binding protein, mRNA processing factor, transcript variant X6
RNA binding protein, mRNA processing factor, transcript variant X9
RNA binding protein, mRNA processing factor, transcript variant X1
RNA binding protein, mRNA processing factor, transcript variant X2
RNA binding protein, mRNA processing factor, transcript variant X8
RNA-binding protein with multiple splicing isoform X1
RNA-binding protein with multiple splicing isoform X8
RNA-binding protein with multiple splicing isoform X5
RNA-binding protein with multiple splicing isoform X7
RNA-binding protein with multiple splicing isoform X3
RNA-binding protein with multiple splicing isoform X6
RNA binding protein, mRNA processing factor, transcript variant X3
RNA-binding protein with multiple splicing isoform X2
RNA binding protein, mRNA processing factor, transcript variant X5
RNA-binding protein with multiple splicing isoform X4
general transcription factor IIE subunit 2, transcript variant X2
general transcription factor IIE subunit 2, transcript variant X3
general transcription factor IIE subunit 2, transcript variant X1
general transcription factor IIE subunit 2, transcript variant X4
transcription initiation factor IIE subunit beta
small integral membrane protein 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small integral membrane protein 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
small integral membrane protein 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LOW QUALITY PROTEIN: glutathione reductase, mitochondrial
protein phosphatase 2 catalytic subunit beta
serine/threonine-protein phosphatase 2A catalytic subunit beta isoform
testis expressed 15, meiosis and synapsis associated, transcript variant X5
testis expressed 15, meiosis and synapsis associated, transcript variant X1
testis expressed 15, meiosis and synapsis associated, transcript variant X2
testis expressed 15, meiosis and synapsis associated, transcript variant X3
testis expressed 15, meiosis and synapsis associated, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC106824647, transcript variant X4
uncharacterized LOC106824647, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC106824647, transcript variant X1
uncharacterized LOC106824647, transcript variant X3
uncharacterized protein LOC106824647 isoform X1
uncharacterized protein LOC106824647 isoform X3
uncharacterized protein LOC106824647 isoform X2
uncharacterized LOC123281472, transcript variant X2
uncharacterized LOC123281472, transcript variant X1
purine rich element binding protein G, transcript variant X2
purine-rich element-binding protein gamma isoform X2
purine rich element binding protein G, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
purine-rich element-binding protein gamma isoform X1
WRN RecQ like helicase, transcript variant X6
WRN RecQ like helicase, transcript variant X1
WRN RecQ like helicase, transcript variant X3
WRN RecQ like helicase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
WRN RecQ like helicase, transcript variant X4
WRN RecQ like helicase, transcript variant X5
uncharacterized LOC123281399, transcript variant X2
uncharacterized LOC123281399, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
pro-neuregulin-1, membrane-bound isoform isoform X5
pro-neuregulin-1, membrane-bound isoform isoform X4
pro-neuregulin-1, membrane-bound isoform isoform X6
pro-neuregulin-1, membrane-bound isoform isoform X9
pro-neuregulin-1, membrane-bound isoform isoform X10
COORDINATES: nucleotide motif:Rfam:12.0:RF00191
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pro-neuregulin-1, membrane-bound isoform isoform X2
pro-neuregulin-1, membrane-bound isoform isoform X1
pro-neuregulin-1, membrane-bound isoform isoform X3
pro-neuregulin-1, membrane-bound isoform isoform X8
pro-neuregulin-1, membrane-bound isoform isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pro-neuregulin-1, membrane-bound isoform isoform X11
pro-neuregulin-1, membrane-bound isoform isoform X12
fucosyltransferase 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
alpha-(1,3)-fucosyltransferase 10 isoform X2
fucosyltransferase 10, transcript variant X4
alpha-(1,3)-fucosyltransferase 10 isoform X3
fucosyltransferase 10, transcript variant X2
fucosyltransferase 10, transcript variant X1
alpha-(1,3)-fucosyltransferase 10 isoform X1
TELO2 interacting protein 2, transcript variant X2
TELO2 interacting protein 2, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
ring finger protein 122, transcript variant X1
ring finger protein 122, transcript variant X2
dual specificity phosphatase 26, transcript variant X2
dual specificity phosphatase 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
uncharacterized LOC123281452, transcript variant X3
uncharacterized LOC123281452, transcript variant X1
uncharacterized LOC123281452, transcript variant X5
uncharacterized LOC123281452, transcript variant X6
uncharacterized LOC123281452, transcript variant X4
uncharacterized LOC123281452, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
potassium calcium-activated channel subfamily U member 1, transcript variant X5
potassium calcium-activated channel subfamily U member 1, transcript variant X1
potassium calcium-activated channel subfamily U member 1, transcript variant X2
potassium calcium-activated channel subfamily U member 1, transcript variant X4
potassium calcium-activated channel subfamily U member 1, transcript variant X3
potassium calcium-activated channel subfamily U member 1, transcript variant X6
potassium calcium-activated channel subfamily U member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium channel subfamily U member 1 isoform X1
potassium channel subfamily U member 1 isoform X2
potassium channel subfamily U member 1 isoform X4
potassium channel subfamily U member 1 isoform X3
potassium channel subfamily U member 1 isoform X6
potassium channel subfamily U member 1 isoform X5
uncharacterized LOC123281443, transcript variant X2
uncharacterized LOC123281443, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns